Clinical trial
Comparison Between the Efficacy of Rivaroxaban vs Enoxaparin in Post-Operative Deep Venous Thrombosis Prophylaxis After Exploratory Laparotomy
NCT07243080 is registered in ClinicalTrials.gov with Mayo Hospital Lahore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison Between the Efficacy of Rivaroxaban vs Enoxaparin in Post-Operative Deep Venous Thrombosis Prophylaxis After Exploratory Laparotomy
- Lead sponsor
- Mayo Hospital Lahore
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- October 10, 2025
- Completion date
- November 15, 2025
- Enrollment
- 212 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
deep venous thromboses, laparotomy patients